Medicure to be delisted from TSX, announces intention to apply for alternative listing on TSX- V or NEX

Medicure Inc. ("Medicure" or the "Company") (TSX:MPH) announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders. The Company anticipates that a transfer of its stock exchange listing to the TSX-V or NEX would occur on or about the TSX delisting date.

Management of the Company notes that a transfer in its stock exchange listing to the TSX-V or NEX would provide greater operational efficiency and lower costs for the Company, while allowing shareholders continued liquidity on a recognized exchange.

As previously announced on June 25, 2009, the Company was subject to an ordinary course delisting review by the TSX as a result of its reliance on the "financial hardship" exemption under Section 604(e) of the TSX Company Manual. The decision of the TSX to delist Medicure's common shares is based on the Company's failure to meet continued listing requirements of the TSX.

The Company is continuing its strategic review process as previously announced on January 13, 2010.

Source:

Medicure Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.